Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders (TAUSSIG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01624142
Recruitment Status : Active, not recruiting
First Posted : June 20, 2012
Last Update Posted : December 20, 2017
Information provided by (Responsible Party):